Off-target effects of thrombolytic drugs: Apolipoprotein A-I proteolysis by alteplase and tenecteplase

Biochemical Pharmacology

Volumn 85, Issue 4, 2013, Pages 525-530

  Gomaraschi, Monica ^a   Ossoli, Alice ^a   Vitali, Cecilia ^a   Pozzi, Silvia ^a   Vitali Serdoz, Laura ^b   Pitzorno, Cristina ^b   Sinagra, Gianfranco ^b   Franceschini, Guido ^a   Calabresi, Laura ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Acute Myocardial infarction; Alteplase; Apolipoprotein A I; Fibrinolysis; High density lipoproteins; Tenecteplase

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; HIGH DENSITY LIPOPROTEIN; TENECTEPLASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG MECHANISM; FEMALE; FIBRINOLYSIS; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AGED; APOLIPOPROTEIN A-I; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84872675416     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.11.023     Document Type: Article

References (25)

1. C.P. Cannon Advances in the medical management of acute coronary syndromes J Thromb Thrombolysis 7 1999 171 189
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 402
3. J. Llevadot, R.P. Giugliano, and E.M. Antman Bolus fibrinolytic therapy in acute myocardial infarction JAMA 286 2001 442 449
4. S.T. Kunitake, G.C. Chen, S-F. Kung, J.W. Schilling, D.A. Hardman, and J.P. Kane Pre-beta high density lipoportein. Unique disposition of apolipoprotein A-I increases suceptibility to proteolysis Arteriosclerosis 10 1990 25 30
5. I. Eberini, L. Calabresi, R. Wait, G. Tedeschi, A. Pirillo, and L. Puglisi Macrophage metalloproteinases degrade high-density-lipoprotein- associated apolipoprotein A-I at both the N- and C-termini Biochem J 362 2002 627 634
6. M. Lee, P. Uboldi, D. Giudice, A.L. Catapano, and P.T. Kovanen Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function J Lipid Res 41 2000 975 984
7. I. Eberini, E. Gianazza, L. Breghi, S. Klugmann, L. Calabresi, and M. Gomaraschi Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients Ann Med 39 2007 306 311
8. M. Gomaraschi, G. Sinagra, L.V. Serdoz, C. Pitzorno, M. Fonda, and L. Cattin The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction Atherosclerosis 202 2009 304 311
9. P. Tanswell, N. Modi, D. Combs, and T. Danays Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction Clin Pharmacokinet 41 2002 1229 1245
10. M. Gomaraschi, W.E. Putt, S. Pozzi, S. Iametti, A. Barbiroli, and F. Bonomi Structure and function of the apoA-IV T347S and Q360H common variants Biochem Biophys Res Commun 393 2010 126 130
11. E. Favari, M. Gomaraschi, I. Zanotti, F. Bernini, M. Lee-Rueckert, and P.T. Kovanen A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-IMilano dimer effectively promotes ATP-binding cassette A1-mediated cell cholesterol efflux J Biol Chem 282 2007 5125 5132
12. I. Judstrom, H. Jukkola, J. Metso, M. Jauhiainen, P.T. Kovanen, and M. Lee-Rueckert Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex vivo Atherosclerosis 208 2010 148 154
13. I. Ott, V. Malcouvier, A. Schomig, and F.J. Neumann Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction Circulation 105 2002 279 281
14. A.B. Federici, S.D. Berkowitz, T.S. Zimmerman, and P.M. Mannucci Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction Blood 79 1992 38 44
15. R.P. Tracy, D.Z. Rubin, K.G. Mann, E.G. Bovill, M. Rand, and D. Geffken Thrombolytic therapy and proteolysis of factor V J Am Coll Cardiol 30 1997 716 724
16. Y.L. Marcel, and R.S. Kiss Structure-function relationships of apolipoprotein A-I: a flexible protein with dynamic lipid associations Curr Opin Lipidol 14 2003 151 157
17. L. Calabresi, M. Gomaraschi, and G. Franceschini Endothelial protection by high-density lipoproteins: from bench to bedside Arterioscler Thromb Vasc Biol 23 2003 1724 1731
18. E. Favari, F. Bernini, P. Tarugi, G. Franceschini, and L. Calabresi The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux Biochem Biophys Res Commun 299 2002 801 805
19. L. Calabresi, G. Tedeschi, C. Treu, S. Ronchi, D. Galbiati, and S. Airoldi Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL J Lipid Res 42 2001 935 942
20. E. Favari, L. Calabresi, M.P. Adorni, W. Jessup, S. Simonelli, and G. Franceschini Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1 Biochemistry 48 2009 11067 11074
21. S.E. Nissen, T. Tsunoda, E.M. Tuzcu, P. Schoenhagen, C.J. Cooper, and M. Yasin Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300
22. J.C. Tardif, J. Gregoire, P.L. L'Allier, R. Ibrahim, J. Lesperance, and T.M. Heinonen Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial JAMA 297 2007 1675 1682
23. N. Fournier, V. Atger, J.L. Paul, M. Sturm, N. Duverger, and G.H. Rothblat Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum Arterioscler Thromb Vasc Biol 20 2000 1283 1292
24. S. Szabo, R. Letsch, R. Ehlers, T. Walter, S. Kazmaier, and U. Helber Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase Thromb Res 106 2002 113 119
25. M. Parsons, N. Spratt, A. Bivard, B. Campbell, K. Chung, and F. Miteff A randomized trial of tenecteplase versus alteplase for acute ischemic stroke N Engl J Med 366 2012 1099 1107